As such, our finding of a comparable rate of LOH rLOH ≈ 2.03 × 10−6/yr on 22q and mutation rate μNF2 ≈1.5 × 10−6/yr (see Table 1) of NF2 might hold more generally for tumours derived from glial precursor cells: while it is not possible to say with certainty without additional modelling, μTP53 and rLOH (17p) (on the same loci) must at least have similar orders of magnitude for alterations to occur with such similar prevalence. Here, NF2 is linked to neoplasm.